FamiCord H1 2026 slides: cash flow surges as EBITDA drops 13.8%

FamiCord AG released its first-half 2026 financial results on August 28, demonstrating a period of stabilization characterized by robust cash flow generation, yet persistent challenges to profitability. The Poland-based stem cell banking and cell therapy services provider reported H1 2026 revenues of EUR 43.2 million, virtually unchanged year-over-year, while EBITDA fell 13.8% to EUR 4.3 million.

Amidst ongoing macroeconomic headwinds, the company's stock price currently stands at $2.80, close to the lower end of its 52-week trading range of $2.58 to $7.30. Despite these profitability pressures, FamiCord maintained its full-year 2026 guidance, projecting revenues between EUR 80-90 million and EBITDA between EUR 9-11 million.

The company's earnings per share turned negative at -EUR 0.08, compared to a minor EUR 0.01 loss in the previous year. FamiCord's H1 2026 financial performance showcased differing trends between stable revenue and declining margins. Revenue grew marginally by 0.9% year-over-year, while gross profit decreased by 7.6% to EUR 25.0 million, indicating potential pricing or cost pressures beyond the modest revenue decline.

EBITDA margin contracted by 1.5 percentage points, reaching 9.9%. However, operating cash flow surged to EUR 3.4 million, a more than thirteen-fold increase from EUR 250,000 in the same period last year. Management attributed this improvement to enhanced working capital management, higher second-quarter revenue, pricing effects, and a trend towards subscription-based customer payments.

Despite the declining profitability, FamiCord affirmed its revenue and EBITDA targets for the fiscal year 2026, signaling cautious optimism amidst the challenging operating environment.